Abstract
Introduction
Gender differences are increasingly recognized as important in numerous diseases and found to be relevant in various cancer entities. While a larger number of manuscripts on gender effects in gastro-intestinal and pulmonary neoplasms have been published, urological malignancies involving men and women alike seem less studied in this regard. The present analysis aimed at describing the role of gender effects in general oncological and uro-oncological research and is the first such bibliometrical analysis.
Methods
The electronic database MEDLINE was searched for relevant medical subject headings from January 1991 to December 2011. Publication types, publishing journal and impact factors were identified. Trends were assessed by linear regression.
Results
The numbers of annual publications on all major tumour entities and on urological malignancies increased similarly. While the portion of publications on gender effects was below 1 % for each tumour entity, the annual increase of novel publications on gender effects was significant in most and prominent in pulmonary (1.87, 95 % CI 1.11–2.63; <0.0001) and colorectal neoplasms (2.16, 95 % CI 1.49–2.82; <0.0001). While the annual increase of novel publications on gender effects was significant in bladder cancer (0.33, 95 % CI 0.11–0.54; 0.005), it failed level of significance in renal cell cancer (0.25, 95 % CI −0.19–0.24; 0.82).
Conclusion
While the overall role of gender effect seems small in general oncological research, it is increasing steadily. In uro-oncological research, such trend is also visible in bladder but not in renal cell cancer. Respective awareness on importance of gender effects should be raised.
Similar content being viewed by others
References
Canadian Institutes of Health Research (CIHR) (2012) What a difference sex and gender make. Retrieved from http://www.cihr-irsc.gc.ca
Alex L, Fjellman Wiklund A, Lundman B, Christianson M, Hammarström A (2012) Beyond a dichotomous view of the concepts of ‘sex’ and ‘gender’ focus group discussions among gender researchers at a medical faculty. PLoS One 7(11):e50275
Verdonk P, Klinge I (2012) Mainstreaming sex and gender analysis in public health genomics. Gend Med 9(6):402–410
González-Ortega I, Echeburúa E, Corral P, Polo-López R, Alberich S (2012) Predictors of pathological gambling severity taking gender differences into account. Eur Addict Res 19(3):146–154
Becker JB, Hu M (2008) Sex differences in drug abuse. Front Neuroendocrinol 29:36–47
van Rijsingen IA, Nannenberg EA, Arbustini E, Elliott PM, Mogensen J, Ast JF, van der Kooi AJ, van Tintelen JP, van den Berg MP, Grasso M, Serio A, Jenkins S, Rowland C, Richard P, Wilde AA, Perrot A, Pankuweit S, Zwinderman AH, Charron P, Christiaans I, Pinto YM (2012) Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers. Eur J Heart Fail 15(4):376–384
Newman JD, Davidson KW, Ye S, Shaffer JA, Shimbo D, Muntner P (2012) Gender differences in calls to 9–1-1 during an acute coronary syndrome. Am J Cardiol 111(1):58–62
Hofer-Dückelmann C (2012) Gender and polypharmacotherapy in the elderly: a clinical challenge. Handb Exp Pharmacol 214:169–182
Morgan CP, Bale TL (2012) Sex differences in microRNA regulation of gene expression: no smoke, just miRs. Biol Sex Differ 3(1):22
Kiyohara C, Ohno Y (2010) Sex differences in lung cancer susceptibility: a review. Gend Med 7(5):381–401
Brändstedt J, Wangefjord S, Nodin B, Gaber A, Manjer J, Jirström K (2012) Gender, anthropometric factors and risk of colorectal cancer with particular reference to tumour location and TNM stage: a cohort study. Biol Sex Differ 3(1):23
Chen CJ, Sung WW, Lin YM, Chen MK, Lee CH, Lee H, Yeh KT, Ko JL (2012) Gender difference in the prognostic role of interleukin 6 in oral squamous cell carcinoma. PLoS One 7(11):e50104
Mandal R, Bolt DM, Shah BK (2012) Disparities in chronic myeloid leukemia survival by age, gender, and ethnicity in pre- and post-imatinib eras in the US. Acta Oncol [Epub ahead of print]
Jacobs-Lawson JM, Schumacher MM, Hughes T, Arnold S (2010) Gender differences in psychosocial responses to lung cancer. Gend Med 7(2):137–148
Fajkovic H, Halpern JA, Cha EK, Bahadori A, Chromecki TF, Karakiewicz PI, Breinl E, Merseburger AS, Shariat SF (2011) Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol 29(4):457–463
Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C, Shariat S, Lotan Y (2012) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63(2):234–241
Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC (2011) Association between smoking and risk of bladder cancer among men and women. JAMA 306(7): 737–745 (Erratum in: JAMA 2011 Nov 23;306(20): 2220)
McCauley LR, Beckham CJ, Hunter TB, Nguyen MM (2011) Gender and renal cancer: do variations in clinical presentation and imaging patterns explain observed differences between males and females? Urology 2010(76):536
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer, Lyon, France. GLOBOCAN 2008 v1.2. Available from: http://globocan.iarc.fr, Accessed on 12 Aug 2012
Hew MN, Zonneveld R, Kümmerlin IP, Opondo D, de la Rosette JJ, Laguna MP (2012) Age and gender related differences in renal cell carcinoma in a European cohort. J Urol 188(1):33–38
Kluth LA, Fajkovic H, Xylinas E, Crivelli JJ, Passoni N, Rouprêt M, Becker A, Comploj E, Pycha A, Holmang S, Gupta A, Lotan Y, Karakiewicz PI, Gontero P, Chun FK, Fisch M, Scherr DS, Shariat SF (2012) Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder. World J Urol [Epub ahead of print]
Otto W, Denzinger S, Wieland WF, Hartmann A (2012) First analysis of immune cell infiltration in stage pT1 urothelial bladder carcinoma: CD3 positivity as a prognostic marker for cancer-specific survival. World J Urol 30(6):875–877
Faba OR, Palou J, Breda A, Villavicencio H (2012) High-risk non-muscle-invasive bladder cancer: update for a better identification and treatment. World J Urol 30(6):833–840
Keck B, Ott OJ, Häberle L, Kunath F, Weiss C, Rödel C, Sauer R, Fietkau R, Wullich B, Krause FS (2012) Female sex is an independent risk factor for reduced overall survival in bladder cancer patients treated by transurethral resection and radio- or radiochemotherapy. World J Urol [Epub ahead of print]
May M, Stief C, Brookman-May S, Otto W, Gilfrich C, Roigas J, Zacharias M, Wieland WF, Fritsche HM, Hofstädter F, Burger M (2012) Gender-dependent cancer-specific survival following radical cystectomy. World J Urol 30(5):707–713
Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Höfner T, Brookman-May S, Nuhn P,Gilfrich C, Roigas J, Zacharias M, Denzinger S, Hohenfellner M, Haferkamp A, Müller SC, Kocot A, Riedmiller H, Wieland WF, Stief CG, Bastian PJ, Burger M (2012) Analysis of gender differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2,500 patients with urothelial carcinoma of the bladder. Gend Med 9(6):481–489
Jentzmik F, Schrader AJ, de Petriconi R, Hefty R, Mueller J, Doetterl J, Eickhoff A, Schrader M (2012) The ileal neobladder in female patients with bladder cancer: long-term clinical, functional, and oncological outcome. World J Urol 30(6):733–739
Shariat SF, Favaretto RL, Gupta A, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Tritschler S, Baba S, Matsushita K, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Otto W, Karakiewicz PI, Ficarra V, Novara G (2011) Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol 29(4):481–486
Lee S, Jeon HG, Kwak C, Kim HH, Byun SS, Lee SE, Lee E (2012) Gender-specific clinicopathological features and survival in patients with renal cell carcinoma (RCC). BJU Int 110(2 Pt 2):E28–E33
Kates M, Whalen MJ, Badalato GM, McKiernan JM (2012) The effect of race and gender on the surgical management of the small renal mass. Urol Oncol (Epub ahead of print)
Brookman-May S, May M, Ficarra V, Kainz MC, Kampel-Kettner K, Kohlschreiber S, Wenzl V, Schneider M, Burger M, Wieland WF, Otto W, Tilki D, Gilfrich C, Hohenfellner M, Pahernik S, Chromecki TF, Stief C, Zigeuner R; Members of the CORONA (Collaborative Research On Renal Neoplasms Association) Project (2012) Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series. World J Urol (Epub ahead of print)
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kunath, F., Keck, B., Bertz, S. et al. Is gender becoming relevant in uro-oncological research? A bibliographical analysis. World J Urol 31, 1065–1072 (2013). https://doi.org/10.1007/s00345-013-1069-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-013-1069-4